Search Results - "Mesh:Baclofen/adverse effects"
-
1
Authors: et al.
Contributors: et al.
Source: Expert Opinion on Drug Safety. :1-8
Subject Terms: Mesh:Follow-Up Studies, Mesh:GABA-B Receptor Agonists/adverse effects, Baclofen, causality, Alcohol Drinking, [SDV]Life Sciences [q-bio], Mesh:Alcohol Drinking/prevention & control, Mesh:Baclofen/adverse effects, Mesh:Off-Label Use, Mesh:Prospective Studies, Cohort Studies, [SCCO]Cognitive science, 03 medical and health sciences, 0302 clinical medicine, Surveys and Questionnaires, patient safety, Mesh:Algorithms, Mesh:Cohort Studies, Humans, off-label use, Mesh:Baclofen/administration & dosage, Prospective Studies, Mesh:France, Mesh:GABA-B Receptor Agonists/administration & dosage, alcoholism, Mesh:Alcoholism/drug therapy, adverse drug reaction reporting systems, Mesh:Telephone, [SCCO] Cognitive science, Off-Label Use, Telephone, 3. Good health, [SDV] Life Sciences [q-bio], Mesh:Humans, Alcoholism, drug-related side effects and adverse reactions, pharmacovigilance, GABA-B Receptor Agonists, telephone, Mesh:Drug Monitoring/methods, France, Drug Monitoring, Mesh:Surveys and Questionnaires, Algorithms, Follow-Up Studies
-
2
Authors: et al.
Contributors: et al.
Source: Drug Safety. 40:257-262
Subject Terms: Mesh:Female, Adult, Male, Baclofen, Adolescent, Databases, Factual, Mesh:Male, Mesh:Young Adult, Mesh:Adult, Mesh:Baclofen/adverse effects, Mesh:Off-Label Use, Pharmacovigilance, Young Adult, 03 medical and health sciences, Mesh:Adolescent, 0302 clinical medicine, Mesh:Middle Aged, Mesh:80 and over, Adverse Drug Reaction Reporting Systems, Humans, Mesh:Baclofen/administration & dosage, Mesh:France, Mesh:Aged, Mesh:Factual, Aged, Mesh:GABA-B Receptor Agonists/administration & dosage, Aged, 80 and over, Mesh:Alcoholism/drug therapy, Mesh:GABA-B Receptor Agonists/adverse effects, Mesh:Databases, [SCCO] Cognitive science, Off-Label Use, Middle Aged, 3. Good health, [SDV] Life Sciences [q-bio], Mesh:Humans, Alcoholism, GABA-B Receptor Agonists, Mesh:Adverse Drug Reaction Reporting Systems/statistics & numerical data, Female, France, Mesh:Pharmacovigilance
Access URL: https://pubmed.ncbi.nlm.nih.gov/27988884
https://econpapers.repec.org/RePEc:spr:drugsa:v:40:y:2017:i:3:d:10.1007_s40264-016-0489-7
https://pubmed.ncbi.nlm.nih.gov/27988884/
https://ideas.repec.org/a/spr/drugsa/v40y2017i3d10.1007_s40264-016-0489-7.html
https://link.springer.com/article/10.1007/s40264-016-0489-7
https://www.ncbi.nlm.nih.gov/pubmed/27988884
https://www.infona.pl/resource/bwmeta1.element.springer-doi-10_1007-S40264-016-0489-7 -
3
Authors: et al.
Contributors: et al.
Source: European Neuropsychopharmacology. 25:1631-1636
Subject Terms: Mesh:Follow-Up Studies, Mesh:Female, Male, Risk, Baclofen, Mesh:Hypnotics and Sedatives/administration & dosage, Alcohol Drinking, Mesh:Male, Mesh:Alcoholism/epidemiology, Drug-related side effects and adverse reactions, Mesh:Baclofen/adverse effects, Mesh:Alcohol Drinking/adverse effects, Mesh:Risk, Mesh:Prospective Studies, 03 medical and health sciences, Mesh:Alcohol Deterrents/adverse effects, 0302 clinical medicine, Mesh:Dose-Response Relationship, Mesh:Middle Aged, Humans, Hypnotics and Sedatives, Mesh:Alcohol Deterrents/administration & dosage, Prospective Studies, GABA agonists, Alcohol-related disorders, Mesh:Alcohol Drinking/epidemiology, Dose-Response Relationship, Drug, Ethanol, Mesh:Alcoholism/drug therapy, Central Nervous System Depressants, [SCCO] Cognitive science, Middle Aged, Mesh:Ethanol/administration & dosage, 3. Good health, [SDV] Life Sciences [q-bio], Mesh:Humans, Alcoholism, Mesh:Drug, Mesh:Hypnotics and Sedatives/adverse effects, Multivariate Analysis, Mesh:Central Nervous System Depressants/administration & dosage, Mesh:Multivariate Analysis, Female, Mesh:Baclofen/administration & dosage, Alcohol Deterrents, Follow-Up Studies
Access URL: https://pubmed.ncbi.nlm.nih.gov/26095229
https://www.sciencedirect.com/science/article/pii/S0924977X15001649
https://www.ncbi.nlm.nih.gov/pubmed/26095229
https://pubmed.ncbi.nlm.nih.gov/26095229/
https://hal.univ-lille.fr/hal-02383815
https://hal.univ-lille.fr/hal-02383815v1
https://doi.org/10.1016/j.euroneuro.2015.05.008 -
4
Authors: et al.
Contributors: et al.
Source: International Clinical Psychopharmacology. 30:49-53
Subject Terms: Male, Mesh:Off-Label Use, Baclofen, Time Factors, Mesh:Time Factors, Comorbidity, Mesh:Adult, 0302 clinical medicine, Mesh:Alcohol Abstinence, 5. Gender equality, Mesh:Risk Factors, Borderline Personality Disorder, Recurrence, Risk Factors, Mesh:Borderline Personality Disorder/epidemiology, Mesh:Case-Control Studies, Mesh:Borderline Personality Disorder/diagnosis, Mesh:Treatment Outcome, alcoholism, Alcohol Abstinence, Mesh:Alcoholism/psychology, Middle Aged, Mesh:Recurrence, 3. Good health, [SDV] Life Sciences [q-bio], Mesh:Alcoholism/diagnosis, Mesh:France/epidemiology, Alcoholism, Treatment Outcome, Mesh:Baclofen/adverse effects, Female, Mesh:Psychiatric Status Rating Scales, France, Mesh:Risk Assessment, Mesh:Baclofen/administration & dosage, Mesh:Borderline Personality Disorder/psychology, Mesh:Female, Adult, Alcohol Drinking, baclofen, Mesh:Male, Mesh:Alcoholism/epidemiology, Risk Assessment, 03 medical and health sciences, Mesh:Middle Aged, Mesh:Alcoholism/surgery, Humans, Psychiatric Status Rating Scales, Mesh:Comorbidity, [SCCO] Cognitive science, Off-Label Use, Mesh:Humans, drug-related side effects and adverse reactions, Case-Control Studies, treatment outcome, Mesh:Alcohol Drinking/prevention & control, borderline personality disorder
-
5
Authors: et al.
Contributors: et al.
Subject Terms: patient safety, Baclofen, drug-related side effects and adverse reactions, pharmacovigilance, adverse drug reaction reporting systems, causality, telephone, off-label use, alcoholism, Mesh:Alcoholism/drug therapy, Mesh:Algorithms, Mesh:Prospective Studies, Mesh:Telephone, Mesh:Off-Label Use, Mesh:Surveys and Questionnaires, Mesh:Alcohol Drinking/prevention & control, Mesh:Baclofen/administration & dosage, Mesh:Baclofen/adverse effects, Mesh:Cohort Studies, Mesh:Drug Monitoring/methods, Mesh:Follow-Up Studies, Mesh:France, Mesh:GABA-B Receptor Agonists/administration & dosage, Mesh:GABA-B Receptor Agonists/adverse effects, Mesh:Humans
File Description: application/octet-stream
Relation: Expert opinion on drug safety; Expert Opin. Drug Saf.; http://hdl.handle.net/20.500.12210/16504
Availability: https://hdl.handle.net/20.500.12210/16504
Nájsť tento článok vo Web of Science 
Full Text Finder